Clinical Trials | June 14, 2024
Moderna announces positive Phase 3 efficacy data for next generation COVID-19 vaccine
Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older
Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
This strategic decision will unlock significant value for our scientific and industrial products business
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
The cancer screening and awareness camp will run for four months in the Mira Bhayander Region, benefiting approximately 5,000 police personnel
Ulcerative Colitis (UC) is a chronic, idiopathic, immune-mediated inflammatory bowel disease (IBD) affecting the large intestine
Subscribe To Our Newsletter & Stay Updated
